2026 NPPES data Pharmacist NPI 1639448269 MD, PHD
Verify on CMS →

Ogechi Ikediobi, MD, PHD

Pharmacist in San Diego, California. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers — including 290,447 in Pharmacist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration — see our methodology.

Federal data — no proprietary rating. We show these CMS records as-is — no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
723
Medicare Part D claims · 299 beneficiaries · Pharmacist avg: 135
Generic prescribing
97%
generic claims · 3% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
98.3/100
▲ 15 pts above national avg 83.1 · Exceptional
Industry payments
$382.07
15 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Ogechi Ikediobi, MD, PHD reported a CMS MIPS final score of 98.3/100 - above the 83.1 national average - and filed 723 Medicare Part D claims in 2023.

98.3/100
MIPS score · +15 vs avg
723
Part D claims, 2023
97%
generic prescribing
$382.07
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

Ogechi Ikediobi, MD, PHD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

98 Top 11% higher than 89% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Ogechi Ikediobi, MD, PHD sits

This provider among pharmacist peers

Across the 37 pharmacist providers who report both Medicare Part D prescribing and a MIPS quality score, Ogechi Ikediobi, MD, PHD writes more Part D claims than 54% of them and scores higher on MIPS quality than 84% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Part D claim volume vs MIPS quality, by specialty percentile

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality0255075100024.749.474.098.7Part D claim volume, percentile in specialtyMIPS quality, percentilePart D claim volume, percentile in specialty: 92 · MIPS quality, percentile: 56Part D claim volume, percentile in specialty: 36 · MIPS quality, percentile: 89Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 61Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 78Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 75Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 53Part D claim volume, percentile in specialty: 97 · MIPS quality, percentile: 72Part D claim volume, percentile in specialty: 64 · MIPS quality, percentile: 22Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 33Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 94Part D claim volume, percentile in specialty: 6 · MIPS quality, percentile: 19Part D claim volume, percentile in specialty: 42 · MIPS quality, percentile: 67Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 92Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 31Part D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 3Part D claim volume, percentile in specialty: 58 · MIPS quality, percentile: 8Part D claim volume, percentile in specialty: 31 · MIPS quality, percentile: 83Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 6Part D claim volume, percentile in specialty: 44 · MIPS quality, percentile: 14Part D claim volume, percentile in specialty: 89 · MIPS quality, percentile: 0Part D claim volume, percentile in specialty: 19 · MIPS quality, percentile: 39Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 14Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 28Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 81Part D claim volume, percentile in specialty: 47 · MIPS quality, percentile: 44Part D claim volume, percentile in specialty: 69 · MIPS quality, percentile: 94Part D claim volume, percentile in specialty: 86 · MIPS quality, percentile: 50Part D claim volume, percentile in specialty: 11 · MIPS quality, percentile: 36Part D claim volume, percentile in specialty: 14 · MIPS quality, percentile: 47Part D claim volume, percentile in specialty: 94 · MIPS quality, percentile: 94Part D claim volume, percentile in specialty: 8 · MIPS quality, percentile: 69Part D claim volume, percentile in specialty: 61 · MIPS quality, percentile: 25Part D claim volume, percentile in specialty: 81 · MIPS quality, percentile: 11Part D claim volume, percentile in specialty: 3 · MIPS quality, percentile: 64Part D claim volume, percentile in specialty: 39 · MIPS quality, percentile: 42Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 58Ogechi Ikediobi, MD, PHD-Part D claim volume, percentile in specialty: 54 · MIPS quality, percentile: 84
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one pharmacist peer from a representative sample of 36; the gold marker is Ogechi Ikediobi, MD, PHD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

What does the federal data show about Ogechi Ikediobi, MD, PHD?

High performer (top quartile)

NPI registry status

Active

Issued 12/28/2011

NPI 1639448269

Primary specialty

Pharmacist

High-volume

290,447 US NPIs in this specialty

Medicare Part D claims

723 vs specialty avg

2023 prescription claims

Specialty avg: 135

MIPS final score

98.3/100 15.2 pts vs avg

Exceptional band

vs 83.1 national avg

Specialty distribution in California

How Pharmacist compares to other specialties among California providers

California providers

Largest specialties in California (% of in-state providers)

Behavior Technician - 17.3%Behavior Technician17.3%Marriage & Family Therapist - 5.5%Marriage & Family Therapist5.5%Student in an Organized Health Care Education/Training Program - 5%Student in an Organized Health Care Education/Training Program5%Mental Health Counselor - 3.9%Mental Health Counselor3.9%Pharmacist - 3.5%Pharmacist3.5%Clinical Social Worker - 3.1%Clinical Social Worker3.1%
Largest specialties in California (% of in-state providers)

Medicare quality performance — MIPS

Ogechi Ikediobi, MD, PHD's 2023 MIPS final score plotted against the Pharmacist national average

High performer (top quartile)
MIPS Final Score
98.3/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Pharmacist) — 98.3/100 vs national avg 83.1

0%100%National avg83%98.3%
MIPS final score (Pharmacist) — 98.3/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Ogechi Ikediobi, MD, PHD appears in the CMS NPPES registry as a Pharmacist provider holding MD, PHD credentials at 8899 UNIVERSITY CENTER LN STE 350, San Diego, CA, 92122, with a listed phone of (858) 657-8322. NPI 1639448269 was issued on 12/28/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Ikediobi most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 723 prescription claims written by this provider, covering 299 Medicare beneficiaries and totaling roughly $54K in drug spend, split 3% brand-name and 97% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 98.3/100 for the 2023 performance year, compared with the national average of 83.1.

Pharmacist is a high-volume specialty nationwide, with 290,447 enrolled providers across 56 states and an average of 135 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

8899 UNIVERSITY CENTER LN STE 350
San Diego, CA 92122

Provider Details

NPI 1639448269
Specialty Pharmacist
Credentials MD, PHD
Gender Female
NPI Issued 12/28/2011

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

98.3
Final Score
Avg: 83.1
98
Promoting Interoperability

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Ogechi Ikediobi, MD, PHD. Source: openpaymentsdata.cms.gov.

Total received

$382

Largest payer

Regeneron Healthcare Solutions, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to Ogechi Ikediobi, MD, PHD. To verify Ogechi Ikediobi, MD, PHD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

Ogechi Ikediobi, MD, PHD — brand share 3.0%
Pharmacist average

3% brand-name claims vs 97% generic, on 723 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

723
Total Claims
$54K
Total Drug Cost
299
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
761
Total Day Supply
20,002
Brand vs Generic
3% brand / 97% generic
Brand Drug Cost
$26K
Generic Drug Cost
$28K
Antibiotic Claims
57

Patient Demographics

Average Patient Age
75.0 years
Avg HCC Risk Score
1.09
Gender Split
65% female / 35% male
Age Distribution
<65: 12, 65-74: 129, 75-84: 114, 85+: 44

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Ogechi Ikediobi, MD, PHD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ketoconazole
153
Mupirocin
99
Clobetasol Propionate
87
Doxycycline Hyclate
47
Triamcinolone Acetonide
38
Fluocinonide
32
Fluorouracil
28
Valacyclovir
Valacyclovir Hcl
28
Azelaic Acid
26
Tacrolimus
22

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacist Overview

How Ogechi Ikediobi, MD, PHD fits within the Pharmacist landscape nationally.

290,447
Pharmacist Providers in US
56
States with Pharmacist
135
Avg Claims per Provider

Ogechi Ikediobi, MD, PHD's 723 claims are above the specialty average of 135.

Nearby Pharmacist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Ikediobi.

Compare Pharmacist nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry — providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the California medical board — federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Pharmacist peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only — they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Ogechi Ikediobi, MD, PHD's specialty?
Ogechi Ikediobi, MD, PHD specializes in Pharmacist and practices in San Diego, California. Credentials: MD, PHD.
How much does Ogechi Ikediobi, MD, PHD prescribe under Medicare Part D?
In 2023, Ogechi Ikediobi, MD, PHD wrote 723 Medicare Part D claims totaling $54K in drug costs for 299 beneficiaries.
What is Ogechi Ikediobi, MD, PHD's Medicare quality score?
Ogechi Ikediobi, MD, PHD has a CMS MIPS Final Score of 98.3/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Ogechi Ikediobi, MD, PHD located?
Ogechi Ikediobi, MD, PHD is located at 8899 UNIVERSITY CENTER LN STE 350, San Diego, CA, 92122. Phone: (858) 657-8322.
What is Ogechi Ikediobi, MD, PHD's NPI number?
Ogechi Ikediobi, MD, PHD's National Provider Identifier (NPI) is 1639448269, issued on 12/28/2011.
Does Ogechi Ikediobi, MD, PHD prescribe more brand-name or generic drugs?
Ogechi Ikediobi, MD, PHD's prescribing is 3% brand-name and 97% generic drugs by claim count, with $26K in brand drug costs.
How many Pharmacist providers are there in the US?
There are 290,447 Pharmacist providers across 56 states in the US. The average Pharmacist provider writes 135 Medicare Part D claims per year.
What drugs does Ogechi Ikediobi, MD, PHD prescribe most often?
Based on 2023 Medicare Part D data, Ogechi Ikediobi, MD, PHD's most frequently prescribed drugs include Ketoconazole, Mupirocin, Clobetasol Propionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Ogechi Ikediobi, MD, PHD accept Medicare?
Ogechi Ikediobi, MD, PHD appears in CMS Medicare data with 723 Part D claims and 299 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Ogechi Ikediobi, MD, PHD's credentials?
Ogechi Ikediobi, MD, PHD's NPI is 1639448269 with credentials MD, PHD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.